Read the third post in this thread. Basically next month we will know the top line results of the FX Phase 2 Trial. Not sure much else will move the price between now and then, but happy to be wrong of course!
We'll also have news regarding upcoming trials for trofinetide in rett (P3 & additional small pediatric)
By end 2015: FXS trial
1st half 2016: TBI trial
2nd half 2016: concussion trial.
Ann: Neuren completes enrolment in INTREPID clinical trial, page-11
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.30 |
Change
-0.200(1.03%) |
Mkt cap ! $2.466B | |||
| Open | High | Low | Value | Volume |
| $19.50 | $19.59 | $19.11 | $5.729M | 296.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 259 | $19.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.31 | 640 | 2 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |